Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 23, 2020 
Livongo Health, Inc.
(Exact name of registrant as specified in its charter) 
 
 
 
 
 
Delaware
 
001-38983
 
26-3542036
(State or other jurisdiction of
incorporation)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
150 West Evelyn Avenue, Suite 150
Mountain View, California 94041
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (866) 435-5643
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
        Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.001 par value
 
LVGO
 
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  






Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 23, 2020, the Compensation Committee of the Board of Directors of Livongo Health, Inc. (the “Company”) adopted an amendment (the “Amendment”) to the Company's 2019 Equity Incentive Plan, 2014 Stock Incentive Plan and 2008 Stock Incentive Plan (collectively, the “Plans”) to formalize a policy regarding the effect of a holder’s death on his or her unvested equity awards covering shares of the Company’s common stock. The Amendment provides that, so long as the holder remains a service provider for the Company at the time of his or her death, (i) 75% of the unvested shares subject to the holder's outstanding awards will be accelerated and vest, and (ii) the remaining 25% of the unvested shares subject to such outstanding awards will not be returned to the applicable Plan. Instead, the Company currently intends to make a donation to Living on the Go Foundation in honor of the deceased holder of a number of shares of the Company’s common stock equal to the remaining 25% of unvested shares.
The foregoing description of the Amendment is qualified in its entirety by reference to the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
 
Description
10.1
 







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 27, 2020

Livongo Health, Inc.
 
 
By:
 
/s/ Lee Shapiro
Name:
 
Lee Shapiro
Title:
 
Chief Financial Officer
 
 
 



Exhibit


Exhibit 10.1

Livongo Health, Inc.
Equity Award Acceleration Policy
Livongo Health, Inc. (the “Company”) desires to formalize a policy regarding the effect of a holder’s death on his or her equity awards covering shares of the Company’s common stock, including stock options, restricted stock, restricted stock units, stock appreciation rights, performance units, performance shares and/or any other equity-based awards (each, an “Equity Award”).
Notwithstanding anything to the contrary in any plan, agreement, or arrangement governing an Equity Award, upon a holder’s death while the holder is a service provider of the Company, the vesting of any Equity Award will accelerate as to 75% of the then-unvested shares subject to such Equity Award (“Accelerated Shares”). For any Equity Award subject to performance-based vesting, the vesting of such Equity Award will accelerate as to 75% of the shares subject to such Equity Award that would have otherwise vested assuming target level of performance or any applicable binary performance condition was achieved.
Further, with respect to the then-unvested shares subject to such Equity Award at death that are not Accelerated Shares (the “Remaining Shares”), such Remaining Shares shall not revert back to the share pool of the applicable equity compensation plan. Instead, in honor of the deceased Equity Award holder, the Company intends to make a donation of a number of shares of Company common stock equal to the Remaining Shares to Living on the Go Foundation.
The provisions of this policy shall apply to all Equity Awards (whether under the Company’s 2019 Equity Incentive Plan, the 2014 Stock Incentive Plan, the 2008 Stock Incentive Plan or any successor equity compensation plan of the Company or an equity incentive plan under which awards are assumed by the Company in a transaction) unless the Company’s Compensation Committee of the Board of Directors specifically determines otherwise with respect to any Equity Award.